PharmaEssentia Corporation (LUX:261280558)
Luxembourg flag Luxembourg · Delayed Price · Currency is EUR · Price in USD
18.70
-0.50 (-2.60%)
At close: Jul 4, 2025

PharmaEssentia Revenue

PharmaEssentia had revenue of 3.26B TWD in the quarter ending March 31, 2025, with 97.00% growth. This brings the company's revenue in the last twelve months to 11.34B, up 93.12% year-over-year. In the year 2024, PharmaEssentia had annual revenue of 9.73B with 90.67% growth.

Revenue (ttm)
11.34B TWD
Revenue Growth
+93.12%
P/S Ratio
16.55
Revenue / Employee
86.55M TWD
Employees
131
Market Cap
5.22B EUR

Revenue Chart

* This company reports financials in TWD.

Revenue History

Fiscal Year End Revenue Change Growth
Dec 31, 2024 9.73B 4.63B 90.67%
Dec 31, 2023 5.11B 2.22B 77.15%
Dec 31, 2022 2.88B 2.23B 339.00%
Dec 31, 2021 656.51M 99.25M 17.81%
Dec 31, 2020 557.26M 251.57M 82.29%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Reinet Investments S.C.A. 798.00M
CPI FIM 167.35M
Luxempart 50.29M
Socfinasia 186.43M
Socfinaf 591.38M
Velcan Holdings 2.95M
GP Investments -8.48M
Revenue Rankings